Aktienanalyse zu So-Young International Inc (SY)SYSo-Young International Inc

So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website. It operates in the Consumer Cyclicals sector (COMPUTER PROCESSING AND DATA PREPARATION AND PROCE industry).

So-Young International Inc is a good buy right now due to its recent revenue growth of 45.6% in Q1 2026, alongside a current price of $2.40, which is below its Fibonacci resistance levels. The stock has shown a 5-day price increase of 4.80%, reflecting positive momentum. However, the main risk is the widening losses, with a net loss of RMB 49.2 million reported in Q1 2026, which could impact investor sentiment.